Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionToll-like receptor 9 (TLR9) agonist
Molecular Target Toll-like receptor 9 (TLR9)
Mechanism of ActionToll-like receptor 9 (TLR9) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationAdjuvant
Indication DetailsVaccine adjuvant
Regulatory Designation
PartnerGlaxoSmithKline plc;
Merck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today